Send to a Friend Font Size: Increase Decrease

UTHR and MNKD Related Headlines

May 6, 2026 06:31AM MannKind develops dry powder inhaler for pulmonary hypertension treatment
May 6, 2026 06:30AM MannKind Announces Ralinepag Dry Powder Inhalation (DPI) Program to be Pursued for Pulmonary Hypertension and Fibrotic Lung Diseases

UTHR and MNKD Related Press Releases

May 6, 2026 06:30AM MannKind Announces Ralinepag Dry Powder Inhalation (DPI) Program to be Pursued for Pulmonary Hypertension and Fibrotic Lung Diseases

UTHR and MNKD Related SEC Filings